PharmaTher Achieves Historic Ketamine FDA Approval After Third Attempt
PharmaTher has secured FDA approval for its ketamine product KETARx, which is specifically for surgical pain management.
Read More
PharmaTher has secured FDA approval for its ketamine product KETARx, which is specifically for surgical pain management.
Read More
Twenty four Arizonans living with post traumatic stress disorder will participate in a groundbreaking study next month.
Read More
The compounded GLP-1 market has become fiercely competitive. Most clinics compete on price and speed. Mindful Labs wants to change
Read More
Psychedelic retreats have moved from the fringes of wellness culture into the full blown mainstream travel market.
Read More
Psilocybin is moving into the mainstream faster than science and policy can keep up. Will this interest in move the
Read More
The FDA's decision could deliver the first psychedelic medicine approved by the FDA as soon as this summer.
Read More
A Chicago company is betting that better mental health treatment starts with a better assessment. MindMetrix has built a comprehensive
Read More
Filament Health CEO Ben Lightburn discusses the challenges of producing natural extracts for psychedelic therapy.
Read More
In Denver, Microdose Mondays classes teach folks about psilocybin mushrooms, and gifts them a month's worth of microdoses. Here's why.
Read More
Albino Penis Envy is a leucistic Penis Envy variant — ~0.9-1.1% psilocybin by weight, roughly 50-80% stronger than common cubensis.
Read More